Drug Topics

DECEMBER 12, 2022

When it comes to practicing pharmacy, do titles and degrees actually matter?

503

503

PhRMA

DECEMBER 12, 2022

If you or a loved one were to receive a diagnosis of a serious or life-threatening disease, you would likely want access to a U.S. Food and Drug Administration (FDA) approved safe and effective medicine as soon as possible. That’s precisely why the accelerated approval pathway was created back in 1992 at the urging of patient advocates. Since then, it has been a lifeline for millions of patients.

FDA 276

FDA 276

Drug Topics

DECEMBER 12, 2022

Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.

500

500

PharmaVoice

DECEMBER 12, 2022

A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.

264

264

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 12, 2022

Online portals are accessible via tablet or computer and can streamline the mental health screening process.

478

478

PharmaVoice

DECEMBER 12, 2022

Here’s a look at how industry leaders are navigating the key issues of 2023.

264

264

PharmaVoice

DECEMBER 12, 2022

Learn why an informed, holistic view is needed to succeed in today’s complex and dynamic landscape.

246

246

Pharmacy Times

DECEMBER 12, 2022

Dapagliflozin (Farxiga) found effective in lowering the risk of hospitalization for patients with chronic kidney disease, with or without a diagnosis of type 2 diabetes, and increased the number of days alive and out of the hospital.

Hospitals 145

Hospitals 145

Fierce Healthcare

DECEMBER 12, 2022

House and Senate Dems want CMS to drop ACO REACH members due to fraud concerns. rking. Mon, 12/12/2022 - 16:08.

139

139

European Pharmaceutical Review

DECEMBER 12, 2022

A thirteen-year-old patient with relapsed T-cell acute lymphoblastic leukaemia (T-ALL) has been the first to be treated with base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy, which enabled them to achieve remission 28 days later. . A unique clinical trial for T-ALL. The patient enrolled in the ongoing clinical trial ( NCT05397184 ) went on to receive a second bone marrow transplant after the therapy.

Chemotherapy 124

Chemotherapy Hospitals 124

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

DECEMBER 12, 2022

Lead compounds may lower the risk of abuse and other adverse effects compared with other drugs currently being evaluated for mental health disorders, such as MDMA.

Compounding 123

Compounding 123

STAT

DECEMBER 12, 2022

Type “Ehlers-Danlos syndromes” into a search engine, and multiple suggestions pop up. Is Ehlers-Danlos an autoimmune disease? Is EDS hereditary? Rare? Then, the algorithm might suggest: Is Ehlers-Danlos syndrome a disease?

120

120

Pharmacy Times

DECEMBER 12, 2022

Following the approval of cabotegravir in 2021, governments and donor agencies in low- and middle-income countries are contemplating replacing oral pre-exposure prophylaxis or augmenting the approach with long-acting treatment.

123

123

The FDA Law Blog

DECEMBER 12, 2022

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert & Lisa M. Baumhardt, Senior Medical Device Regulation Expert — With the explosion of health‑related software, many software developers are generating products with functionality that is subject to regulation by the Food and Drug Administration (FDA). If you are a manufacturer of implants that go into the human body for the treatment of disease, it’s an easy yes that you are a manufacturer of a medical device.

Documentation 23

Documentation FDA Communication 23

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

DECEMBER 12, 2022

Relatives who attend low-intensity coaching and monitoring meetings increase individuals’ ability to manage the disease.

123

123

Fierce Healthcare

DECEMBER 12, 2022

Healthcare companies' default risk steadily rising, with most owned by private equity: Moody's. hlandi. Mon, 12/12/2022 - 22:05.

119

119

Pharmacy Times

DECEMBER 12, 2022

Five crucial steps pharmacies can take to enhance patient engagement and lower operational costs.

123

123

Fierce Pharma

DECEMBER 12, 2022

Watch out, Amgen. Mirati kicks off KRAS showdown with FDA approval for Krazati. aliu. Mon, 12/12/2022 - 18:14.

FDA 116

FDA 116

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

DECEMBER 12, 2022

ED docs offer better care than nurse practitioners, research finds. fdiamond. Mon, 12/12/2022 - 16:05.

116

116

STAT

DECEMBER 12, 2022

Curative rose to prominence during the throes of the pandemic, as people and governments across the country used its Covid-19 tests. But that business is now firmly in the past, and the company has switched to an even more regulated industry: health insurance. Last year, Curative had a cloud hanging over its head. It got into trouble with the Food and Drug Administration and states, which said the company’s tests led to too many false negatives, meaning the tests may have told patients th

Health Insurance Companies 112

Health Insurance Companies Insurance FDA 112

Drug Store News

DECEMBER 12, 2022

From CoQ10 to omega-3s, supplements for the heart are supported by compelling research.

112

112

PharmExec

DECEMBER 12, 2022

The move bolsters Evoke’s digital innovation and omnichannel offering.

111

111

Fierce Healthcare

DECEMBER 12, 2022

Federal appeals court strikes down Biden admin's transgender care mandate. hlandi. Mon, 12/12/2022 - 06:58.

108

108

European Pharmaceutical Review

DECEMBER 12, 2022

The Scottish Medicines Consortium (SMC) has accepted Utrogestan, the only adjunctive micronised progesterone available as hormone replacement therapy (HRT) for use alongside any oestrogen-only HRT for women with an intact uterus. Utrogestan 100mg, a product by Besins Healthcare UK, is a body-identical hormone, which means it has the same molecular structure as the hormone produced by the body.

105

105

Pharmaceutical Technology

DECEMBER 12, 2022

Pipeline therapies within the cardiometabolic space have recently gathered interest following the 20th World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) Hybrid Conference, which took place on 1–3 December. The spotlight was placed on many up-and-coming pharmacotherapies within the space, one of which was Amgen’s obesity therapy, AMG-133, following the company’s announcement of its Phase I therapy results last week, on 1 December.

105

105

pharmaphorum

DECEMBER 12, 2022

In a fresh update, Bloomberg has reported that US biotech Amgen Inc. has agreed to purchase Dublin-based Horizon Therapeutics Plc. for €24.7 billion ($26bn), in a deal which could yet see further delays or a breakdown in negotiations. Following Sanofi’s withdrawal from the running, stating that “transaction price expectations do not meet [their] value creation criteria” – for the purposes of Rule 2.12 of the Irish Takeover Rules in response to Horizon’s announcement under Rule 2.4 of the I

105

105

Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. The alliance will utilise the capabilities of both firms, including international cell therapy leadership and manufacturing of Kite.

Communication 105

Communication 105

pharmaphorum

DECEMBER 12, 2022

The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector. But, although open opportunities are diminishing and time slots are being squeezed, MSLs are emerging as the ideal ambassadors to ensure the science and data reaches the right targets and makes connections.

Communication 104

Communication 104

Fierce Healthcare

DECEMBER 12, 2022

Home ovulation diagnostic startup Proov brings hormone insights to Google Health Connect. aburky. Mon, 12/12/2022 - 13:11.

103

103

STAT

DECEMBER 12, 2022

A coalition of pharmaceutical industry and academic medical research associations based in Germany is calling for the indefinite suspension of a new European system to register clinical trials, citing “serious shortcomings” that need to be fixed. In a strongly worded statement released late last month, the organizations expressed concern that the clinical trial information system, or CTIS, suffers from “deficiencies” that have only worsened since it debuted this past

103

103

European Pharmaceutical Review

DECEMBER 12, 2022

The Scottish Medicines Consortium (SMC) has approved Utrogestan, the only adjunctive micronised progesterone available as hormone replacement therapy (HRT) for use alongside any oestrogen-only HRT for women with an intact uterus. Utrogestan 100mg, a product by Besins Healthcare UK, is a body-identical hormone, which means it has the same molecular structure as the hormone produced by the body.

98

98

STAT

DECEMBER 12, 2022

Amgen said Monday it would purchase Horizon Pharmaceuticals for $27.8 billion, marking the latest bet by a large pharmaceutical company on the lucrative market for treating a rare disease. The deal is the largest pharma merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies 102

Drug Store News

DECEMBER 12, 2022

Curology will launch seven of its bestselling and dermatologist-formulated products, as well as an exclusive Starter Set, at Target.

98

98